Cassia Cinnamon Supplementation Reduces Peak Blood Glucose Responses but Does Not Improve Insulin Resistance and Sensitivity in Young, Sedentary, Obese Women

Jean Gutierrez, Rodney G. Bowden, Darryn S. Willoughby

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

Cassia cinnamon has been suggested to lower blood glucose (BG) and serum insulin (SI) due to an improvement in insulin resistance (IR) and sensitivity (IS). This study compared the effects Cassia cinnamon had on calculated IR and IS values and BG and SI in response to an oral glucose tolerance test (OGTT) in young, sedentary, and obese women. On three separate days, 10 women had a fasted venous blood sample obtained. Participants were given 5 g of encapsulated placebo (PLC) or 5 g of encapsulated Cassia cinnamon bark (CASS). Three hours after the initial blood sample, another blood sample was obtained to calculate values for IS and IR. The participants then completed an OGTT by consuming a 75 g glucose solution. Blood was obtained 30, 60, 90, and 120 min following glucose ingestion. IS and IR were not significantly different between placebo and Cassia (p >.05). The peak BG concentration in response to the OGTT was significantly lower at the 30 min time point for CASS, as compared to PLC (140 ± 5.8 and 156 ± 5.2 mg/dL, p =.025); however, there was no significant difference between treatments for SI (p >.05). The area-under-the-curve responses for BG and SI were not significantly different between PLC and CASS (p >.05). This study suggests that a 5 g dose of Cassia cinnamon may reduce the peak BG response and improve glucose tolerance following an OGTT, but with no improvement in IS and IR in young, sedentary, obese women.

Original languageEnglish (US)
Pages (from-to)461-471
Number of pages11
JournalJournal of Dietary Supplements
Volume13
Issue number4
DOIs
StatePublished - Jul 3 2016

Fingerprint

Cassia
Cinnamomum zeylanicum
cinnamon
insulin resistance
blood glucose
Insulin Resistance
Blood Glucose
blood serum
placebos
Glucose Tolerance Test
insulin
Placebos
Insulin
blood
Serum
Glucose
glucose
glucose tolerance
sampling
bark

Keywords

  • blood glucose
  • Cassia
  • cinnamon
  • insulin
  • prediabetes

ASJC Scopus subject areas

  • Food Science
  • Nutrition and Dietetics
  • Pharmacology (medical)

Cite this

Cassia Cinnamon Supplementation Reduces Peak Blood Glucose Responses but Does Not Improve Insulin Resistance and Sensitivity in Young, Sedentary, Obese Women. / Gutierrez, Jean; Bowden, Rodney G.; Willoughby, Darryn S.

In: Journal of Dietary Supplements, Vol. 13, No. 4, 03.07.2016, p. 461-471.

Research output: Contribution to journalArticle

@article{d6d7a0227b2444d5a93b4ccca95b1d83,
title = "Cassia Cinnamon Supplementation Reduces Peak Blood Glucose Responses but Does Not Improve Insulin Resistance and Sensitivity in Young, Sedentary, Obese Women",
abstract = "Cassia cinnamon has been suggested to lower blood glucose (BG) and serum insulin (SI) due to an improvement in insulin resistance (IR) and sensitivity (IS). This study compared the effects Cassia cinnamon had on calculated IR and IS values and BG and SI in response to an oral glucose tolerance test (OGTT) in young, sedentary, and obese women. On three separate days, 10 women had a fasted venous blood sample obtained. Participants were given 5 g of encapsulated placebo (PLC) or 5 g of encapsulated Cassia cinnamon bark (CASS). Three hours after the initial blood sample, another blood sample was obtained to calculate values for IS and IR. The participants then completed an OGTT by consuming a 75 g glucose solution. Blood was obtained 30, 60, 90, and 120 min following glucose ingestion. IS and IR were not significantly different between placebo and Cassia (p >.05). The peak BG concentration in response to the OGTT was significantly lower at the 30 min time point for CASS, as compared to PLC (140 ± 5.8 and 156 ± 5.2 mg/dL, p =.025); however, there was no significant difference between treatments for SI (p >.05). The area-under-the-curve responses for BG and SI were not significantly different between PLC and CASS (p >.05). This study suggests that a 5 g dose of Cassia cinnamon may reduce the peak BG response and improve glucose tolerance following an OGTT, but with no improvement in IS and IR in young, sedentary, obese women.",
keywords = "blood glucose, Cassia, cinnamon, insulin, prediabetes",
author = "Jean Gutierrez and Bowden, {Rodney G.} and Willoughby, {Darryn S.}",
year = "2016",
month = "7",
day = "3",
doi = "10.3109/19390211.2015.1110222",
language = "English (US)",
volume = "13",
pages = "461--471",
journal = "Journal of Dietary Supplements",
issn = "1939-0211",
publisher = "Informa Healthcare",
number = "4",

}

TY - JOUR

T1 - Cassia Cinnamon Supplementation Reduces Peak Blood Glucose Responses but Does Not Improve Insulin Resistance and Sensitivity in Young, Sedentary, Obese Women

AU - Gutierrez, Jean

AU - Bowden, Rodney G.

AU - Willoughby, Darryn S.

PY - 2016/7/3

Y1 - 2016/7/3

N2 - Cassia cinnamon has been suggested to lower blood glucose (BG) and serum insulin (SI) due to an improvement in insulin resistance (IR) and sensitivity (IS). This study compared the effects Cassia cinnamon had on calculated IR and IS values and BG and SI in response to an oral glucose tolerance test (OGTT) in young, sedentary, and obese women. On three separate days, 10 women had a fasted venous blood sample obtained. Participants were given 5 g of encapsulated placebo (PLC) or 5 g of encapsulated Cassia cinnamon bark (CASS). Three hours after the initial blood sample, another blood sample was obtained to calculate values for IS and IR. The participants then completed an OGTT by consuming a 75 g glucose solution. Blood was obtained 30, 60, 90, and 120 min following glucose ingestion. IS and IR were not significantly different between placebo and Cassia (p >.05). The peak BG concentration in response to the OGTT was significantly lower at the 30 min time point for CASS, as compared to PLC (140 ± 5.8 and 156 ± 5.2 mg/dL, p =.025); however, there was no significant difference between treatments for SI (p >.05). The area-under-the-curve responses for BG and SI were not significantly different between PLC and CASS (p >.05). This study suggests that a 5 g dose of Cassia cinnamon may reduce the peak BG response and improve glucose tolerance following an OGTT, but with no improvement in IS and IR in young, sedentary, obese women.

AB - Cassia cinnamon has been suggested to lower blood glucose (BG) and serum insulin (SI) due to an improvement in insulin resistance (IR) and sensitivity (IS). This study compared the effects Cassia cinnamon had on calculated IR and IS values and BG and SI in response to an oral glucose tolerance test (OGTT) in young, sedentary, and obese women. On three separate days, 10 women had a fasted venous blood sample obtained. Participants were given 5 g of encapsulated placebo (PLC) or 5 g of encapsulated Cassia cinnamon bark (CASS). Three hours after the initial blood sample, another blood sample was obtained to calculate values for IS and IR. The participants then completed an OGTT by consuming a 75 g glucose solution. Blood was obtained 30, 60, 90, and 120 min following glucose ingestion. IS and IR were not significantly different between placebo and Cassia (p >.05). The peak BG concentration in response to the OGTT was significantly lower at the 30 min time point for CASS, as compared to PLC (140 ± 5.8 and 156 ± 5.2 mg/dL, p =.025); however, there was no significant difference between treatments for SI (p >.05). The area-under-the-curve responses for BG and SI were not significantly different between PLC and CASS (p >.05). This study suggests that a 5 g dose of Cassia cinnamon may reduce the peak BG response and improve glucose tolerance following an OGTT, but with no improvement in IS and IR in young, sedentary, obese women.

KW - blood glucose

KW - Cassia

KW - cinnamon

KW - insulin

KW - prediabetes

UR - http://www.scopus.com/inward/record.url?scp=84958928046&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84958928046&partnerID=8YFLogxK

U2 - 10.3109/19390211.2015.1110222

DO - 10.3109/19390211.2015.1110222

M3 - Article

VL - 13

SP - 461

EP - 471

JO - Journal of Dietary Supplements

JF - Journal of Dietary Supplements

SN - 1939-0211

IS - 4

ER -